US Broker Ratings

Illumina, Inc. (ILMN) Stock Analysis: Exploring Growth Potential Amidst Mixed Analyst Ratings

Illumina, Inc. (NASDAQ: ILMN), a leader in the healthcare sector’s diagnostics and research industry, offers investors a compelling opportunity to delve into the burgeoning field of genetic and genomic analysis...

Boston Scientific Corporation (BSX) Stock Analysis: Strong Buy Ratings Signal Potential 61% Upside

Boston Scientific Corporation (NYSE: BSX) continues to capture investor attention with its robust market presence in the healthcare sector, specifically within the medical devices industry. As a major player based..

BeOne Medicines Ltd. (ONC) Stock Analysis: Exploring the 52.5% Upside Potential in Biotech

Investors looking to capitalize on the burgeoning field of biotechnology may find BeOne Medicines Ltd. (ONC) a compelling opportunity, particularly given the projected 52.5% upside potential based on current analyst..

Hologic, Inc. (HOLX) Stock Analysis: Steady Growth with a Focus on Women’s Health

Hologic, Inc. (NASDAQ: HOLX), a prominent player in the healthcare sector, commands a significant presence in the medical instruments and supplies industry. With a market capitalization of $16.97 billion, Hologic..

Gilead Sciences, Inc. (GILD): Investor Outlook Reveals 22% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a leading biopharmaceutical company headquartered in Foster City, California, presents an intriguing proposition for investors, particularly with its potential upside of 22.20%. With a market..

UnitedHealth Group (UNH) Stock Analysis: Evaluating Growth Potential Amidst a Robust $362 Billion Market Cap

As one of the cornerstones of the healthcare sector, UnitedHealth Group Incorporated (NYSE: UNH) stands out with its significant market capitalization of $362.78 billion. For investors seeking exposure to the..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring a 36% Upside Potential in the Healthcare Sector

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable presence in the U.S. healthcare sector, commanding a significant market capitalization of $82.55 billion. As a leading provider in the medical..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 13.70% Potential Upside with a Strong Dividend Yield

Viatris Inc. (VTRS), a prominent player in the healthcare sector, is making headlines with its potential upside of 13.70% and a robust dividend yield of 3.02%. With a market capitalization..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating a 43.3% Potential Upside Despite Financial Challenges

Tempus AI, Inc. (NASDAQ: TEM) is capturing the attention of investors with its innovative approach to healthcare technology. Operating within the Health Information Services industry, this U.S.-based company offers a..

Exelixis, Inc. (EXEL) Stock Analysis: A Promising Player in Biotechnology with Strong Revenue Growth

Exelixis, Inc. (NASDAQ: EXEL) has emerged as a notable contender in the biotechnology sector, specializing in the development of innovative treatments for challenging cancer types. With a market capitalization of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Exploring Growth Potential Amidst a 6.95% Upside

For investors with a keen eye on the healthcare sector, Dr. Reddy’s Laboratories Ltd (NYSE: RDY), an Indian pharmaceutical giant, presents a compelling case. With a market capitalization of $11.02..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Exploring a 31% Upside Potential and Robust Growth Metrics

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a prominent player in the biotechnology industry, situated within the expansive healthcare sector. With a market capitalization of $66.62 billion, this U.S.-based company continues..

Humana Inc. (HUM) Stock Analysis: Navigating a 23.50% Revenue Surge Amidst Valuation Challenges

Humana Inc. (NYSE: HUM), a prominent player in the healthcare sector, specifically within healthcare plans, currently holds a market capitalization of $42.03 billion. The Louisville, Kentucky-based company is a major..

Tenet Healthcare Corporation (THC): A 50.91% Potential Upside Awaits Investors

Tenet Healthcare Corporation (NYSE: THC) is making waves in the healthcare sector with a promising outlook that could pique the interest of investors seeking substantial returns. With a market capitalization..

The Cooper Companies, Inc. (COO) Stock Analysis: Potential 19.97% Upside and Strong Buy Ratings in Focus

The Cooper Companies, Inc. (NYSE: COO), a noteworthy player in the healthcare sector, offers intriguing investment potential with its dual focus on contact lenses and women’s healthcare. With a market..

Neurocrine Biosciences (NBIX) Stock Analysis: A 17.7% Potential Upside Beckons Investors

Neurocrine Biosciences, Inc. (NBIX), a prominent player in the healthcare sector, focuses on the discovery and commercialization of pharmaceuticals targeting neurological, psychiatric, endocrine, and immunological disorders. With a market cap..

ResMed Inc. (RMD) Stock Analysis: Unveiling a 38% Potential Upside Amid Strong Market Position

ResMed Inc. (NYSE: RMD) stands as a formidable player in the healthcare sector, specializing in the development and distribution of medical devices and cloud-based software applications aimed at managing respiratory..

DaVita Inc. (DVA) Stock Analysis: Is This Healthcare Giant Poised for Growth?

DaVita Inc. (NYSE: DVA), a key player in the healthcare sector specializing in medical care facilities, primarily provides dialysis services for patients with chronic kidney failure. With a robust market..

Koninklijke Philips N.V. (PHG) Stock Analysis: A 28% Upside in the Healthcare Sector?

For investors eyeing opportunities within the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents a compelling case. As a leading player in the medical devices industry, Philips is headquartered in..

The Cigna Group (CI) Stock Analysis: Strong Buy Ratings and Potential Upside of 17.62%

The Cigna Group (NYSE: CI) is making waves in the healthcare sector, with a robust market capitalization of $76.58 billion. As a stalwart in the healthcare plans industry, Cigna’s strategic..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds